February 3, 2021 at 8:30 AM ESTPDF Version Study reached primary and secondary endpoints of safety and immunogenicity, respectivelyVXA-CoV2-1 induced...
Malcom
Thomas Ghgnone is the Head of Legal Affairs at Sanofi. He came to the attention of Vaxart investors when he...
December 8, 2021 As news leaked out that the Covid-19 vaccine being developed by Pfizer and BioNTech was about to...
Some NHP study material. It includes the major vaccine player's NHP studies, some correlate info and how these compare to...
by Eric Sagonowsky | Dec 1, 2021 1:29pm While Sanofi hasn’t been at the forefront of global COVID-19 vaccination efforts, the company still...
Might be good to have a vaccine that targets the lungs and the gastrointestinal system and is delivered to the...
Dec. 09, 2021 2:41 PM ET This article was written by Edmund Ingham Summary Vaxart is the oral vaccine developer...